NYSE: COHRCoherent Corp Stock
$51.51+2.25 (+4.57%)
Updated Apr 22, 2024
COHR Price
$51.51
Fair Value Price
N/A
Market Cap
$7.82B
52 Week Low
$26.29
52 Week High
$67.94
P/E
-18.27x
P/B
1.43x
P/S
1.42x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.63B
Earnings
-$270.21M
Gross Margin
30.7%
Operating Margin
-1.3%
Profit Margin
-8.7%
Debt to Equity
1.19
Operating Cash Flow
$600M
Beta
1.43
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
COHR Overview
Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a range of commercial, industrial, and scientific research applications. It operates in two segments, Original Equipment Manufacturers (OEM) Laser Sources and Industrial Lasers & Systems. The company designs, manufactures, markets, and services lasers, laser tools, precision optics, and related accessories; and laser measurement and control products. Its products are used for applications in microelectronics, materials processing, OEM components and instrumentation, and scientific research and government programs. The company markets its products through a direct sales force in the United States, as well as through direct sales personnel and independent representatives internationally. Coherent, Inc. was founded in 1966 and is headquartered in Santa Clara, California. As of July 1, 2022, Coherent, Inc. operates as a subsidiary of II-VI Incorporated.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how COHR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
COHR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
COHR is good value based on its book value relative to its share price (1.43x), compared to the US Scientific & Technical Instruments industry average (3.08x)
P/B vs Industry Valuation
COHR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more COHR due diligence checks available for Premium users.
Be the first to know about important COHR news, forecast changes, insider trades & much more!
COHR News
Valuation
COHR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-18.27x
Industry
-5.06x
Market
41x
COHR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.43x
Industry
3.08x
COHR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
COHR's financial health
Profit margin
Revenue
$1.1B
Net Income
-$27.0M
Profit Margin
-5.1%
COHR's Earnings (EBIT) of -$60.39M... subscribe to Premium to read more.
Interest Coverage Financials
COHR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.7B
Liabilities
$6.5B
Debt to equity
1.19
COHR's short-term assets ($3.42B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
COHR's long-term liabilities ($5.33B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
COHR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
COHR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$67.2M
Investing
-$91.5M
Financing
$876.6M
COHR's operating cash flow ($599.93M)... subscribe to Premium to read more.
Debt Coverage Financials
COHR vs Scientific & Technical Instrument Stocks
Coherent Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.